Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Diabetes / Metabolic Neurology Rheumatology Women's Health Mental Health / Psychiatry Dermatology Rare Diseases Men's Health
Clinical Trial ● Currently Recruiting Non-phase study NCT07687849

RESCUE: A Workplace Dietary Intervention for UK Firefighters

RESCUE: A Workplace Dietary Intervention for UK Firefighters — Recruiting • Non-phase study • Oncology • NCT07687849.

📅 07 Jul 2026 ⏱ 2 min read
Currently Recruiting
This trial is actively seeking participants in the UK. Discuss eligibility with your patient before referring.
Status
Currently Recruiting
Phase
Non-phase study
NCT ID
NCT07687849
Sponsor
Avon Fire and Rescue Service
Start
2026-05-05
ClinicaliQ Trial Snapshot
  • RESCUE: A Workplace Dietary Intervention for UK Firefighters — Recruiting • Non-phase study • Oncology • NCT07687849.
  • What is being tested: A workplace dietary intervention programme designed to improve nutritional habits and food choices among UK firefighters, addressing the specific challenges of shift work and limited healthy food availability within fire station environments.
  • Patient eligibility overview: UK firefighters employed at participating fire stations, with focus on those experiencing poor dietary habits related to occupational demands such as irregular shift patterns and extended duty periods.
Use This Page For
  • Quick orientation before opening the registry record.
  • Checking recruitment status, phase and sponsor at a glance.
  • Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying

Firefighters may be at increased risk of poor dietary habits due to nature of shift work, extended duty periods, and reliance on food available within fire station environments. Irregular working patterns and limited access to healthy food options during shifts can contribute to poorer dietary intake. Previous research suggests that occupational environments and works schedules can significantly influence food choices and overall nutrition in emergency service personnel (Ramey, 2012; Hughes, 2010). This study is being conducted to assess current dietary behaviours among firefighters and to evaluate changes following participation in…

Eligibility Snapshot
  • : Wholetime (full-time) operational firefighters employed by Avon Fire & Rescue Service. Aged 18 years or over. Able to provide informed consent.

Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.

Full Trial Details
View this trial on the source registry
Eligibility criteria, protocol, and results when available
View Trial ↗
Share: Twitter/X LinkedIn
Related

Related Clinical Intelligence

Guidelines, Drug Science, safety briefs and education connected to this trial area.

Clinical Brief
‘My cancer spread while I waited months for surgery’: The cost of England’s cancer wait times
Oncology · BBC Health · 10 Sep 2026
England's cancer surgery waiting times have deteriorated despite government initiatives aimed at improving them, with patients experiencing significant delays that may allow…
View brief →
Clinical Brief
Very hot drinks may damage the food pipe and increase cancer risk
Oncology · BBC Health · 09 Sep 2026
The International Agency for Research on Cancer (IARC) has classified drinking "very hot" beverages (>65°C) as a probable carcinogen (Group 2A), associated…
View brief →
Clinical Brief
Very hot drinks may damage the food pipe and increase cancer risk
Oncology · BBC Health · 08 Sep 2026
The International Agency for Research on Cancer has classified drinking "very hot" beverages (above 65°C) as probably carcinogenic, with repeated thermal injury…
View brief →
Guideline
Acalabrutinib with venetoclax with or without obinutuzumab for untreated chronic lymphocytic leukaemia
Oncology · 19 Aug 2026
Use acalabrutinib with venetoclax ± obinutuzumab as first-line treatment for untreated CLL – this combination is recommended by NICE and offers improved…
View guideline →
Guideline
Pembrolizumab with chemoradiotherapy for untreated locally advanced cervical cancer
Oncology · 14 Jul 2026
Pembrolizumab combined with chemoradiotherapy is recommended for untreated locally advanced cervical cancer, improving survival outcomes compared to chemoradiotherapy alone—consider this combination as…
View guideline →
Guideline
Cemiplimab for treating recurrent or metastatic cervical cancer that has progressed on or after platinum-based chemotherapy
Oncology · 09 Jul 2026
Cemiplimab is recommended as a treatment option for patients with recurrent or metastatic cervical cancer only after progression on or following platinum-based…
View guideline →